Regarding this, Ward et al. indicated the potent antitumor effects due to the dual inhibition of the Sonic hedgehog (SHH) and CXCR4 pathways in a murine model of SHH-subtype medulloblastoma [145]. The gene discussed is CXCR4; the disease is medulloblastoma.